Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,905.00
-70.00 (-1.76%)
At close: Feb 13, 2026

Korea Arlico Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
15,95115,48419,06623,3959,5205,506
Short-Term Investments
585.06652.726,1646,51213,61210,544
Trading Asset Securities
2,0713,0575,5602,2965,6163,466
Cash & Short-Term Investments
18,60819,19430,79032,20328,74719,516
Cash Growth
23.71%-37.66%-4.39%12.02%47.30%-47.50%
Accounts Receivable
32,39130,07322,36219,88619,30419,207
Other Receivables
380.0150.1246.58110.4674.88151.41
Receivables
32,77130,12322,40919,99719,37919,359
Inventory
33,92932,79826,77927,43719,75918,918
Prepaid Expenses
-7.057.977.255.787.23
Other Current Assets
2,1493,2123,5702,479964.07184.17
Total Current Assets
87,45785,33483,55582,12368,85557,984
Property, Plant & Equipment
62,47463,15266,74049,72631,64126,661
Long-Term Investments
8,3018,73010,1379,31312,1689,367
Other Intangible Assets
6,3737,1487,0136,9583,9674,402
Long-Term Accounts Receivable
---0000
Long-Term Deferred Tax Assets
6,4716,1404,3654,0713,7412,834
Other Long-Term Assets
1,658859.021,6661,344688.899,040
Total Assets
173,734172,363173,477153,536121,062110,288
Accounts Payable
6,8537,3254,8514,8065,1113,365
Accrued Expenses
6,29810,69911,86812,40710,038342
Short-Term Debt
42,52641,53739,33025,06410,2624,220
Current Portion of Long-Term Debt
2,6671,932-2,000191.43,216
Current Portion of Leases
245.28250.58152.42151.3582.241.57
Current Income Taxes Payable
510.38--883.22840.4982.53
Current Unearned Revenue
---2.46--
Other Current Liabilities
16,64313,45214,11911,9447,24414,812
Total Current Liabilities
75,74375,19570,32057,25833,77026,980
Long-Term Debt
5,6116,5926,7463,7462,0002,191
Long-Term Leases
99.51145.6561.2135.0565.2133.16
Pension & Post-Retirement Benefits
1,508610.34--727.58247.85
Other Long-Term Liabilities
11,70910,1407,2753,8513,3703,270
Total Liabilities
94,67192,68484,40264,99039,93332,721
Common Stock
7,6647,6647,6647,6647,6644,911
Additional Paid-In Capital
40,47340,14340,14340,14340,14342,919
Retained Earnings
34,90435,52043,74343,15635,90431,983
Treasury Stock
-3,082-3,082-3,082-3,082-3,082-2,536
Comprehensive Income & Other
-895.46-565.06608.09665.54501.14290.23
Shareholders' Equity
79,06379,67989,07588,54681,12977,566
Total Liabilities & Equity
173,734172,363173,477153,536121,062110,288
Total Debt
51,14850,45746,28931,09612,6019,702
Net Cash (Debt)
-32,540-31,263-15,4991,10716,1469,814
Net Cash Growth
----93.14%64.53%-20.89%
Net Cash Per Share
-2170.22-2082.32-526.6273.291071.03650.58
Filing Date Shares Outstanding
15.0115.0115.0115.0115.0114.36
Total Common Shares Outstanding
15.0115.0115.0115.0115.0114.36
Working Capital
11,71410,13913,23524,86535,08531,004
Book Value Per Share
5266.195307.225933.045897.815403.785400.05
Tangible Book Value
72,69072,53182,06281,58877,16273,164
Tangible Book Value Per Share
4841.714831.125465.905434.345139.545093.59
Land
-10,88411,40610,1889,6077,151
Buildings
-25,04630,18112,82415,65514,011
Machinery
-15,33431,5278,82215,96114,075
Construction In Progress
-9,76710,78416,4181,608584.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.